A randomised, multi‐centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol

Patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) show varying degrees of response to intravenous immunoglobulin (IVIg) therapy. This randomised phase III study in patients with CIDP (ProCID trial) will compare the efficacy and safety of 3 different doses (0.5, 1.0, and...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Peripher Nerv Syst
Asıl Yazarlar: Cornblath, David R., Hartung, Hans‐Peter, Katzberg, Hans D., Merkies, Ingemar S. J., van Doorn, Pieter A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wiley Periodicals, Inc. 2018
Konular:
Research Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6033152/
https://ncbi.nlm.nih.gov/pubmed/29603842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jns.12267
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller